FDA offers electronic option

Bringing a new drug to market is a paperwork-intensive process, and much of the paper goes to the Food and Drug Administration.

By William JacksonGCN StaffBringing a new drug to market is a paperwork-intensive process, and much of the paper goes to the Food and Drug Administration.'When an application comes in, it might be delivered on a pallet,' said Randy Levin, associate director for electronic review in FDA's Center for Drug Evaluation and Research (CDER) in Rockville, Md.The archived copies for a single application can run to hundreds or thousands of volumes, not counting the copies used by reviewers or the ongoing test records and post-marketing data that must be submitted and maintained by drug companies.Since August 1997, FDA offices have had the option of accepting such documents in electronic form'an option CDER has taken advantage of.'All of that can come in on a digital tape,' Levin said. The tape, once mounted on a network drive at CDER's main office in Rockville, makes the documents in Adobe Portable Document Format available to FDA reviewers from Maryland to Missouri.'The logistics are much easier just to preserve the documents and move them around,' Levin said. It also is easier to extract and manipulate the data electronically.CDER, along with the centers for Biologics Evaluation and Research and for Veterinary Medicine, was one of the first FDA offices prepared to accept electronic documents. CDER began receiving them in 1997.Not all submissions are electronic, however'in fact, fewer than half are. But last year, 250 submissions came in electronic format, and in March alone, 40 electronic submissions arrived.'The pace is picking up,' Levin said.Last year, 58 companies submitted electronic documents. The paperless move was a long time coming, said Paul Motisse, FDA consumer safety officer.'We did a lot of homework going back to the early 1990s, when the industry approached us about using digital signatures,' he said.The problem was, federal regulations did not allow for digital signatures. Title 21 of the Code of Federal Regulations for the pharmaceutical industry contained 132 references to physical signatures. So FDA geared up for a massive overhaul of signature rules, soliciting comments about proposed new rules in July 1992.The final rule, Part 11 of Title 21, took effect in August 1997. It specified minimum standards for records maintained by drug companies and for documents that must be submitted to FDA. Included in the standards are requirements for digitally signing and tying signatures to the documents.Now, as federal offices face a 2003 deadline for accepting electronic paperwork, 'Part 11 is emerging as a model for other parts of government,' Motisse said.Companies that maintain electronic copies of documents required by FDA must use digital signatures that are tied to the signer'usually by means of a digital certificate'and to the document to prove legally that it was not altered after signing.Some companies use ApproveIT from Silanis Technology Inc. of Dorval, Quebec, to tie digital signatures to documents. ApproveIT encrypts a signature using a public-private key pair and can provide an X.509 certificate to authenticate the signer.CDER avoids the need for a separate certificate authority and public-key infrastructure by not accepting signatures digitally. Everything that requires a signature must be submitted on paper.'We don't require a signature on every document,' Levin said.For every three or four pages that must be signed and submitted on paper, there are gigabytes of data that can be handled electronically.'When we first started this, we archived the equivalent of millions of pages electronically,' Levin said.The agency hasn't kept a page count, but last year it stored 200G of electronic data. CDER has no plans to set up a system to accept digital signatures.'This is a small part of the whole submission,' Levin said of the signed pages. 'It's not a high priority for us.'Electronic documents reside on one or more servers running Microsoft Windows NT in each CDER building, most of them located in Rockville. The three main buildings are connected by a Fiber Distributed Data Interface network. Another five buildings link to the network by T1 lines. Each floor has a 10-Mbps Ethernet segment.CDER has enough equipment and wiring to take switched Ethernet to each desk, said Greg Brolund, associate director for technology and policy for CDER's information technology office.'We're gearing up for it,' Brolund said, after 'converting all the T1 lines and leased FDDI to dedicated fiber.'Eventually the network will be converted to Fast Ethernet with switched Ethernet to desktop PCs, but boosting that bandwidth is not a priority until the T1 links are eliminated, Brolund said.Only two remote buildings, one in Beltsville, Md., and one in St. Louis, will retain their T1 lines, he said.Meanwhile, CDER is expanding the kinds of documents it can accept electronically and is trying to help reviewers adapt.'We're a paper-oriented society,' Levin said, and some people accept the change to electronics more rapidly than others.An upgrade to 19- and 20-inch monitors has made an entire page readable at once. Some users have dual monitors to ease searches and comparisons.
Agency moves mountains of paperwork by accepting drug documentation on tape








FDA often receives more than a palletload of documentation for a new drug application. This is the paperwork for one drug.














Picking up steam







































More changes ahead









NEXT STORY: INTERNAUT

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.